BRIEF-Merck Canada says BRENZYS approved in Canada

Mon Sep 12, 2016 8:18am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Sept 12 (Reuters) - Merck Canada Inc:

* BRENZYS approved in Canada for treatment of adult patients with moderate to severe rheumatoid arthritis and ankylosing spondylitis Source text for Eikon: Further company coverage: